LTF and COVID-19: Furthermore, several in vitro and in vivo studies demonstrated lactoferrin’s ability to enhance immune responses [21,161] and to reduce the expression of key pro-inflammatory mediators of the COVID-19-associated cytokine storm, such as IL6 and TNFα [146,162,163], thus fostering the design of several clinical studies aimed at evaluating its effectiveness in modifying disease evolution.